Skip to main content

Hepatitis A Pediatric Vaccine Dosage

Medically reviewed by Last updated on Dec 14, 2021.

Applies to the following strengths: 25 units/0.5 mL; 720 units/0.5 mL; 720 units/0.5 mL preservative free

Usual Pediatric Dose for Hepatitis A Prophylaxis

1 year and older: 0.5 mL intramuscularly

  • Administer a booster 0.5 mL dose 6 to 18 months after the first dose

  • Administer in the deltoid region in children 2 years and older.
  • Administer in the anterolateral aspect of the thigh in younger children.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available



  • Hypersensitivity to any of the ingredients including neomycin
  • Hypersensitivity to previous hepatitis A vaccination

Safety and efficacy have not been established in patients younger than 1 year.

To report suspected adverse reactions, contact the Vaccine Adverse Event Reporting System (VAERS) at:

Consult WARNINGS section for additional precautions.


Data not available.

Other Comments

Administration advice:

  • For intramuscular use only.
  • Do not administer in the gluteal area as a suboptimal response may occur.
  • Do not administer intravenously, intradermally, or subcutaneously.
  • Primary immunization should be given at least 2 weeks prior to expected exposure to hepatitis A.

Storage requirements:
  • Refrigerate; do not freeze

Reconstitution/preparation techniques:
  • Shake well before use.

More about hepatitis a pediatric vaccine

Patient resources

Other brands

Havrix Pediatric, Vaqta Pediatric

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.